Myeloproliferative neoplasms (MPNs) are clinically characterized by the chronic overproduction of differentiated peripheral blood cells and the gradual expansion of malignant intramedullary/extramedullary hematopoiesis. In MPNs mutations in JAK2 MPL or CALR are detected mutually exclusive in more than 90% of cases [1, 2] . Mutations in them lead to the abnormal activation of JAK/STAT signaling and the autonomous growth of differentiated cells therefore they are considered as "driver" gene mutations. In addition to the above driver gene mutations mutations in epigenetic regulators such as TET2 DNMT3A ASXL1 EZH2 or IDH1/2 are detected in about 5%-30% of cases respectively [3] . Mutations in TET2 DNMT3A EZH2 or IDH1/2 commonly confer the increased selfrenewal capacity on normal hematopoietic stem cells (HSCs) but they do not lead to the autonomous growth of differentiated cells and only exhibit subtle clinical phenotypes [4, [6] [7] [8] 5] . It was unclear how mutations in such epigenetic regulators influenced abnormal HSCs with driver gene mutations how they influenced the disease phenotype or whether a single driver gene mutation was sufficient for the initiation of human MPNs. Therefore we focused on JAK2V617F and loss of TET2-the former as a representative of driver gene mutations and the latter as a representative of mutations in epigenetic regulators-and examined the influence of single or double mutations on HSCs (Lineage − Sca-1 + c-Kit + cells (LSKs)) by functional analyses and microarray whole-genome expression analyses [9] . Gene expression profiling showed that the HSC fingerprint genes [10] was statistically equally enriched in TET2-knockdown-LSKs but negatively enriched in JAK2V617F-LSKs compared to that in wild-type-LSKs. Double-mutant-LSKs showed the same tendency as JAK2V617F-LSKs in terms of their HSC fingerprint genes but the expression of individual genes differed between the two groups. Among 245 HSC fingerprint genes 100 were more highly expressed in double-mutant-LSKs than in JAK2V617F-LSKs. These altered gene expressions might partly explain the mechanisms of initiation and progression of MPNs which was observed in the functional analyses [9] . Here we describe gene expression profiles deposited at the Gene Expression Omnibus (GEO) under the accession number GSE62302 including experimental methods and quality control analyses.
Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms Takuro Experimental design, materials and methods
Mouse usage
JAK2V617F transgenic mice [11] and TET2 heterozygous knockdown (TET2 trap/+ ) mice [5] generated by gene trapping were previously reported. They were backcrossed at least 8 times onto C57BL/6 mice (B6-CD45.2). The TET2 trap/trap mice frequently died during the neonatal period on the B6-CD45.2 background; therefore, we transplanted their fetal liver (FL) cells (FLs) to generate mouse models of myeloproliferative neoplasms (MPNs). For the transplantation, we crossed male JAK2V617F-TET2 trap/+ mice with female TET2 trap/+ mice, and obtained the following 4 experimental groups of E14.5 fetuses: JAK2WT-TET2WT (wild-type (WT)), JAK2WT-TET2 trap/trap (TET2-knockdown (TET2KD)), JAK2V617F-TET2WT (JAK2V617F), and JAK2V617F-TET2 trap/trap (double-mutant) ( Table 1) . B6 mice congenic for the CD45.1 locus (B6-CD45.1) were purchased as recipients (Sankyo Laboratory Service, Tsukuba, Japan). Animal studies were performed in accordance with the local University of Miyazaki Ethics Committee.
Generation of mouse models of MPNs
We non-competitively transplanted 1 × 10 6 of 4 experimental groups of E14.5 FLs (WT, TET2KD, JAK2V617F, double-mutant) into lethally irradiated B6-CD45.1 mice [9] . Compared with the recipients transplanted with WT cells, the recipients of TET2KD cells showed normal blood cell count, no splenomegaly, comparable overall survival duration, and minimal extramedullary hematopoiesis of the lung and . WT-LSKs (n = 1), TET2KD-LSKs (n = 1), JAK2V617F-LSKs (n = 1), and double-mutant-LSKs (n = 1) were each pooled from 5 mice (Table 1) , and preserved in TRIzol reagent. RNA samples were isolated from the each pooled 2-6 × 10 4 BM-LSKs. cDNA samples were prepared from 2-5 ng RNA samples using the Ovation Pico WTA System V2 (NuGEN, San Carlos, CA), according to the manufacturer's instructions. The NuGEN Ovation amplification methodology uses an isothermal linear amplification using DNA/RNA chimeric primers.
cDNA labeling and hybridization
Two μg of purified and amplified cDNA was used as input into the Agilent Genomic DNA Enzymatic Labeling Kit (Agilent Technologies, Palo Alto, CA), according to the manufacturer's instructions. The Cy3-labeled cDNA was quantified and dye incorporation determined by Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). For each hybridization, 1.65 μg of Cy3-labeled cDNA was hybridized at 65°C for 17 h to an Agilent Mouse GE 8x60K Microarray (Agilent, Design ID: 028005). After washing, microarrays were scanned using an Agilent DNA microarray scanner (Agilent).
Microarray study design
Using the 4 experimental groups of prepared cDNA samples (each, n = 1), microarray gene expression analyses were performed. Each gene expression profile of TET2KD-LSKs, JAK2V617F-LSKs and doublemutant-LSKs was compared to that of WT-LSKs; and a gene expression profile of double-mutant-LSKs was compared to that of JAK2V617F-LSKs.
RNA and cDNA quality control analyses RNA and cDNA qualities were assessed by Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific) and by the 2100 Bioanalyser (Agilent). All isolated RNA samples showed appropriate A260/A280 ratios ranging between 1.56 and 1.72, but small peaks for 18 s and 28 s ribosomal RNA subunits and low RNA integrity numbers (RIN) ranging between 2.7 and 5.4 in their electropherograms, probably because of their small amounts or degradation; suggesting their insufficient qualities for the regular microarray protocol without amplification ( Fig. 1 left column) . However, according to the manufacturer's instructions, the NuGEN Ovation Pico WTA System V2 enables RNA samples with RIN still around 2.0 to amplify successfully and reproducibly; therefore we performed following RNA amplification and cDNA synthesis. All amplified cDNA samples showed A260/A280 ratios ranging between 1.92 and 1.96, A260/A230 ratio between 2.30 and 2.36, and typical plots between 200 and 2000 kb; indicating their sufficient qualities for the microarray protocol with amplification ( Fig. 1 right column) . Finally, all Cy3-labeled cDNA samples showed A260/A280 ratios ranging between 1.79 and 1.84, and dye incorporation rates ranging between 32.1 and 35.1.
Microarray quality control analyses
In each 4 experimental group of hybridization, the grid placements were adequate (Fig. 2A) . Obvious biases in the distributions of outlier probes were not seen, and the frequencies of non-uniform features were sufficiently low (b1%) (Fig. 2B) .
Data normalization
There are total of 55,681 probes on Agilent Mouse GE 8x60K Microarray (Design ID: 028005) without control probes, and intensity values of each scanned feature were quantified using Agilent Feature Extraction software version 10.7.3.1, which performs background subtractions. Normalization was performed using Agilent GeneSpring GX version 12.6.1. (per chip: normalization to 75 percentile shift).
Data analysis (cluster analysis)
Dendrogram was constructed from unsupervised hierarchical clustering of data sets from 4 experimental groups of BM-LSKs using Pearson correlation. There were close similarities in the whole-genome expression profiles between JAK2V617F-LSKs and double-mutant-LSKs (Fig. 3) .
Data analysis (gene set enrichment analysis (GSEA))
Gene set enrichment analysis (GSEA) [12] was performed across the complete list of genes ranked by signal-to-noise ratio according to their differential expression. A normalized enrichment score (NES) was assigned to each gene set and the statistical significance of its enrichment was measured by FDR q-value. Consistent with the finding from cluster analysis, GSEA showed positive enrichment of the STAT5A target genes [13] and pre-erythroid colony-forming unit signature genes [14] in both JAK2V617F-LSKs and double-mutant LSKs, but not in TET2KD-LSKs; suggesting that JAK2V617F expression induced a progenitor phenotype in LSKs (Fig. 4A, B) . Although there was no significant enrichment of the HSC fingerprint genes [10] in TET2KD-LSKs, it was negatively enriched in JAK2V617F-LSKs. Double-mutant-LSKs showed the same tendency as JAK2V617F-LSKs in terms of their HSC fingerprint genes, but the expression of individual genes differed between the two groups (Fig. 4C, D) . Among 245 HSC fingerprint genes, 100 (41%) genes were highly expressed in double-mutant LSKs, compared to in JAK2V617F-LSKs; and 37 (15%), 16 (6.5%), 6 (2.4%) and 2 (0.8%) genes showed more than 1.0 log2 fold change (log2FC) (2 FC), 2.0 log2FC (4 FC), 3.0 log2FC (8 FC) and 5.0 log2FC (32 FC), respectively ( Table 2 , Fig. 5 ).
Discussion
We present here a unique data set of mouse models of MPNs. This dataset is measured by Agilent platform and composed of gene expression profiles of normal and mutant LSKs (WT, JAK2V617F, TET2KD, double-mutant) ( Table 1) . JAK2V617F-induced HSC impairments were identified in several mouse models of MPNs including ours [9, 15, 16] . In our model, though single-mutant JAK2V617F-cells could initiate and promote MPNs during a short-term, they showed reduced selfrenewal capacity in vitro and reduced long-term oncogenic capacity in vivo [9] . However, the double-mutant cells showed increased self- renewal capacity and could initiate and promote MPNs over the longterm [9] , indicating that JAK2V617F-induced HSC impairments were restored by combined loss of TET2. Also in human, those impairments were identified in JAK2V617F-HSCs [17] , and combined loss of TET2 seemed to restore the JAK2V617F-induced HSC impairments and expand the HSC compartment by altering transcriptional programs [17, 18] . Therefore, we tried to uncover the restoration mechanisms by using a gene-profiling approach in mouse models. Here, we showed that many HSC fingerprint genes were down-regulated in JAK2V617F-LSKs, but the expressions of significant number of them were restored in double-mutant-LSKs (Table 2 , Fig. 5 ), though we could not see statistically significant restoration of the profile (Fig. 4D) . These expressional changes might partly explain the mechanisms of initiation and progression of MPNs. In spite of our and other studies [9, 18, 19 ], the precise mechanisms by which loss of TET2 restores the JAK2V617F-induced HSC impairments still remain poorly known, further wet and dry investigations are necessary to uncover them more precisely. 
